Global Vaccines Market Growth 2020-2025

Global Vaccines Market Growth 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vaccines Consumption 2015-2025
2.1.2 Vaccines Consumption CAGR by Region
2.2 Vaccines Segment by Type
2.2.1 Recombinant Vaccines
2.2.2 Viral Vaccines
2.2.3 Polysaccharide Vaccines
2.2.4 Others
2.3 Vaccines Consumption by Type
2.3.1 Global Vaccines Consumption Market Share by Type (2015-2020)
2.3.2 Global Vaccines Revenue and Market Share by Type (2015-2020)
2.3.3 Global Vaccines Sale Price by Type (2015-2020)
2.4 Vaccines Segment by Application
2.4.1 Cholera
2.4.2 Hepatitis B
2.4.3 Diphtheria
2.4.4 Tetanus
2.4.5 Measles vaccine
2.4.6 Hepatitis A
2.4.7 Live attenuated influenza vaccine
2.4.8 Polio vaccine
2.4.9 Rabies vaccine
2.5 Vaccines Consumption by Application
2.5.1 Global Vaccines Consumption Market Share by Type (2015-2020)
2.5.2 Global Vaccines Value and Market Share by Type (2015-2020)
2.5.3 Global Vaccines Sale Price by Type (2015-2020)

3 Global Vaccines by Company
3.1 Global Vaccines Sales Market Share by Company
3.1.1 Global Vaccines Sales by Company (2018-2020)
3.1.2 Global Vaccines Sales Market Share by Company (2018-2020)
3.2 Global Vaccines Revenue Market Share by Company
3.2.1 Global Vaccines Revenue by Company (2018-2020)
3.2.2 Global Vaccines Revenue Market Share by Company (2018-2020)
3.3 Global Vaccines Sale Price by Company
3.4 Global Vaccines Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Vaccines Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Vaccines by Regions
4.1 Vaccines by Regions
4.2 Americas Vaccines Consumption Growth
4.3 APAC Vaccines Consumption Growth
4.4 Europe Vaccines Consumption Growth
4.5 Middle East & Africa Vaccines Consumption Growth

5 Americas
5.1 Americas Vaccines Consumption by Countries
5.1.1 Americas Vaccines Consumption by Countries (2015-2020)
5.1.2 Americas Vaccines Value by Countries (2015-2020)
5.2 Americas Vaccines Consumption by Type
5.3 Americas Vaccines Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Vaccines Consumption by Regions
6.1.1 APAC Vaccines Consumption by Regions (2015-2020)
6.1.2 APAC Vaccines Value by Regions (2015-2020)
6.2 APAC Vaccines Consumption by Type
6.3 APAC Vaccines Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Vaccines by Countries
7.1.1 Europe Vaccines Consumption by Countries (2015-2020)
7.1.2 Europe Vaccines Value by Countries (2015-2020)
7.2 Europe Vaccines Consumption by Type
7.3 Europe Vaccines Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Vaccines by Countries
8.1.1 Middle East & Africa Vaccines Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Vaccines Value by Countries (2015-2020)
8.2 Middle East & Africa Vaccines Consumption by Type
8.3 Middle East & Africa Vaccines Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Vaccines Distributors
10.3 Vaccines Customer

11 Global Vaccines Market Forecast
11.1 Global Vaccines Consumption Forecast (2021-2025)
11.2 Global Vaccines Forecast by Regions
11.2.1 Global Vaccines Forecast by Regions (2021-2025)
11.2.2 Global Vaccines Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Vaccines Forecast by Type
11.8 Global Vaccines Forecast by Application

12 Key Players Analysis
12.1 GSK
12.1.1 Company Information
12.1.2 Vaccines Product Offered
12.1.3 GSK Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 GSK Latest Developments
12.2 Tiantan
12.2.1 Company Information
12.2.2 Vaccines Product Offered
12.2.3 Tiantan Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Tiantan Latest Developments
12.3 Sanofi
12.3.1 Company Information
12.3.2 Vaccines Product Offered
12.3.3 Sanofi Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Sanofi Latest Developments
12.4 Pfizer
12.4.1 Company Information
12.4.2 Vaccines Product Offered
12.4.3 Pfizer Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Pfizer Latest Developments
12.5 Novartis(GSK)
12.5.1 Company Information
12.5.2 Vaccines Product Offered
12.5.3 Novartis(GSK) Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Novartis(GSK) Latest Developments
12.6 Merck
12.6.1 Company Information
12.6.2 Vaccines Product Offered
12.6.3 Merck Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Merck Latest Developments
12.7 J&J(Crucell)
12.7.1 Company Information
12.7.2 Vaccines Product Offered
12.7.3 J&J(Crucell) Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 J&J(Crucell) Latest Developments
12.8 CSL
12.8.1 Company Information
12.8.2 Vaccines Product Offered
12.8.3 CSL Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 CSL Latest Developments
12.9 China National Biotec
12.9.1 Company Information
12.9.2 Vaccines Product Offered
12.9.3 China National Biotec Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 China National Biotec Latest Developments
12.10 MedImmune LLC
12.10.1 Company Information
12.10.2 Vaccines Product Offered
12.10.3 MedImmune LLC Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 MedImmune LLC Latest Developments
12.11 Hualan
12.11.1 Company Information
12.11.2 Vaccines Product Offered
12.11.3 Hualan Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Hualan Latest Developments
12.12 Jintan
12.12.1 Company Information
12.12.2 Vaccines Product Offered
12.12.3 Jintan Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Jintan Latest Developments
12.13 Hissen
12.13.1 Company Information
12.13.2 Vaccines Product Offered
12.13.3 Hissen Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Hissen Latest Developments
12.14 Kangtai
12.14.1 Company Information
12.14.2 Vaccines Product Offered
12.14.3 Kangtai Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Kangtai Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Vaccines Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Recombinant Vaccines
Table 5. Major Players of Viral Vaccines
Table 6. Major Players of Polysaccharide Vaccines
Table 7. Major Players of Others
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Vaccines Consumption Market Share by Type (2015-2020)
Table 10. Global Vaccines Revenue by Type (2015-2020) ($ million)
Table 11. Global Vaccines Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Vaccines Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Vaccines Consumption Market Share by Application (2015-2020)
Table 15. Global Vaccines Value by Application (2015-2020)
Table 16. Global Vaccines Value Market Share by Application (2015-2020)
Table 17. Global Vaccines Sale Price by Application (2015-2020)
Table 18. Global Vaccines Sales by Company (2017-2019) (K Pcs)
Table 19. Global Vaccines Sales Market Share by Company (2017-2019)
Table 20. Global Vaccines Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Vaccines Revenue Market Share by Company (2017-2019)
Table 22. Global Vaccines Sale Price by Company (2017-2019)
Table 23. Global Vaccines Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Vaccines Products Offered
Table 25. Vaccines Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Vaccines Consumption by Regions 2015-2020 (K Pcs)
Table 27. Global Vaccines Consumption Market Share by Regions 2015-2020
Table 28. Global Vaccines Value by Regions 2015-2020 ($ Millions)
Table 29. Global Vaccines Value Market Share by Regions 2015-2020
Table 30. Americas Vaccines Consumption by Countries (2015-2020) (K Pcs)
Table 31. Americas Vaccines Consumption Market Share by Countries (2015-2020)
Table 32. Americas Vaccines Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Vaccines Value Market Share by Countries (2015-2020)
Table 34. Americas Vaccines Consumption by Type (2015-2020) (K Pcs)
Table 35. Americas Vaccines Consumption Market Share by Type (2015-2020)
Table 36. Americas Vaccines Consumption by Application (2015-2020) (K Pcs)
Table 37. Americas Vaccines Consumption Market Share by Application (2015-2020)
Table 38. APAC Vaccines Consumption by Countries (2015-2020) (K Pcs)
Table 39. APAC Vaccines Consumption Market Share by Countries (2015-2020)
Table 40. APAC Vaccines Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Vaccines Value Market Share by Regions (2015-2020)
Table 42. APAC Vaccines Consumption by Type (2015-2020) (K Pcs)
Table 43. APAC Vaccines Consumption Market Share by Type (2015-2020)
Table 44. APAC Vaccines Consumption by Application (2015-2020) (K Pcs)
Table 45. APAC Vaccines Consumption Market Share by Application (2015-2020)
Table 46. Europe Vaccines Consumption by Countries (2015-2020) (K Pcs)
Table 47. Europe Vaccines Consumption Market Share by Countries (2015-2020)
Table 48. Europe Vaccines Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Vaccines Value Market Share by Countries (2015-2020)
Table 50. Europe Vaccines Consumption by Type (2015-2020) (K Pcs)
Table 51. Europe Vaccines Consumption Market Share by Type (2015-2020)
Table 52. Europe Vaccines Consumption by Application (2015-2020) (K Pcs)
Table 53. Europe Vaccines Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Vaccines Consumption by Countries (2015-2020) (K Pcs)
Table 55. Middle East & Africa Vaccines Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Vaccines Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Vaccines Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Vaccines Consumption by Type (2015-2020) (K Pcs)
Table 59. Middle East & Africa Vaccines Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Vaccines Consumption by Application (2015-2020) (K Pcs)
Table 61. Middle East & Africa Vaccines Consumption Market Share by Application (2015-2020)
Table 62. Vaccines Distributors List
Table 63. Vaccines Customer List
Table 64. Global Vaccines Consumption Forecast by Countries (2021-2025) (K Pcs)
Table 65. Global Vaccines Consumption Market Forecast by Regions
Table 66. Global Vaccines Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Vaccines Value Market Share Forecast by Regions
Table 68. Global Vaccines Consumption Forecast by Type (2021-2025) (K Pcs)
Table 69. Global Vaccines Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Vaccines Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Vaccines Value Market Share Forecast by Type (2021-2025)
Table 72. Global Vaccines Consumption Forecast by Application (2021-2025) (K Pcs)
Table 73. Global Vaccines Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Vaccines Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Vaccines Value Market Share Forecast by Application (2021-2025)
Table 76. GSK Product Offered
Table 77. GSK Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 78. GSK Main Business
Table 79. GSK Latest Developments
Table 80. GSK Basic Information, Company Total Revenue (in $ million), Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 81. Tiantan Product Offered
Table 82. Tiantan Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 83. Tiantan Main Business
Table 84. Tiantan Latest Developments
Table 85. Tiantan Basic Information, Company Total Revenue (in $ million), Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 86. Sanofi Product Offered
Table 87. Sanofi Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 88. Sanofi Main Business
Table 89. Sanofi Latest Developments
Table 90. Sanofi Basic Information, Company Total Revenue (in $ million), Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 91. Pfizer Product Offered
Table 92. Pfizer Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 93. Pfizer Main Business
Table 94. Pfizer Latest Developments
Table 95. Pfizer Basic Information, Company Total Revenue (in $ million), Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 96. Novartis(GSK) Product Offered
Table 97. Novartis(GSK) Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 98. Novartis(GSK) Main Business
Table 99. Novartis(GSK) Latest Developments
Table 100. Novartis(GSK) Basic Information, Company Total Revenue (in $ million), Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 101. Merck Product Offered
Table 102. Merck Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 103. Merck Main Business
Table 104. Merck Latest Developments
Table 105. Merck Basic Information, Company Total Revenue (in $ million), Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 106. J&J(Crucell) Product Offered
Table 107. J&J(Crucell) Basic Information, Company Total Revenue (in $ million), Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 108. J&J(Crucell) Main Business
Table 109. J&J(Crucell) Latest Developments
Table 110. J&J(Crucell) Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 111. CSL Product Offered
Table 112. CSL Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 113. CSL Main Business
Table 114. CSL Latest Developments
Table 115. CSL Basic Information, Company Total Revenue (in $ million), Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 116. China National Biotec Product Offered
Table 117. China National Biotec Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 118. China National Biotec Main Business
Table 119. China National Biotec Latest Developments
Table 120. China National Biotec Basic Information, Company Total Revenue (in $ million), Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 121. MedImmune LLC Product Offered
Table 122. MedImmune LLC Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 123. MedImmune LLC Main Business
Table 124. MedImmune LLC Latest Developments
Table 125. MedImmune LLC Basic Information, Company Total Revenue (in $ million), Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 126. Hualan Product Offered
Table 127. Hualan Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 128. Hualan Main Business
Table 129. Hualan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 130. Hualan Latest Developments
Table 131. Jintan Product Offered
Table 132. Jintan Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 133. Jintan Main Business
Table 134. Jintan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 135. Jintan Latest Developments
Table 136. Hissen Product Offered
Table 137. Hissen Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 138. Hissen Main Business
Table 139. Hissen Latest Developments
Table 140. Hissen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 141. Kangtai Product Offered
Table 142. Kangtai Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 143. Kangtai Main Business
Table 144. Kangtai Latest Developments
Table 145. Kangtai Basic Information, Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Vaccines
Figure 2. Vaccines Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Vaccines Consumption Growth Rate 2015-2025 (K Pcs)
Figure 5. Global Vaccines Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Recombinant Vaccines
Figure 7. Product Picture of Viral Vaccines
Figure 8. Product Picture of Polysaccharide Vaccines
Figure 9. Product Picture of Others
Figure 10. Global Vaccines Consumption Market Share by Type (2015-2020)
Figure 11. Global Vaccines Value Market Share by Type (2015-2020)
Figure 12. Vaccines Consumed in Cholera
Figure 13. Global Vaccines Market: Cholera (2015-2020) (K Pcs)
Figure 14. Global Vaccines Market: Cholera (2015-2020) ($ Millions)
Figure 15. Vaccines Consumed in Hepatitis B
Figure 16. Global Vaccines Market: Hepatitis B (2015-2020) (K Pcs)
Figure 17. Global Vaccines Market: Hepatitis B (2015-2020) ($ Millions)
Figure 18. Vaccines Consumed in Diphtheria
Figure 19. Global Vaccines Market: Diphtheria (2015-2020) (K Pcs)
Figure 20. Global Vaccines Market: Diphtheria (2015-2020) ($ Millions)
Figure 21. Vaccines Consumed in Tetanus
Figure 22. Global Vaccines Market: Tetanus (2015-2020) (K Pcs)
Figure 23. Global Vaccines Market: Tetanus (2015-2020) ($ Millions)
Figure 24. Vaccines Consumed in Measles vaccine
Figure 25. Global Vaccines Market: Measles vaccine (2015-2020) (K Pcs)
Figure 26. Global Vaccines Market: Measles vaccine (2015-2020) ($ Millions)
Figure 27. Vaccines Consumed in Hepatitis A
Figure 28. Vaccines Consumed in Live attenuated influenza vaccine
Figure 29. Vaccines Consumed in Polio vaccine
Figure 30. Vaccines Consumed in Rabies vaccine
Figure 31. Global Vaccines Consumption Market Share by Application (2015-2020)
Figure 32. Global Vaccines Value Market Share by Application (2015-2020)
Figure 33. Global Vaccines Sales Market Share by Company in 2017
Figure 34. Global Vaccines Sales Market Share by Company in 2019
Figure 35. Global Vaccines Revenue Market Share by Company in 2017
Figure 36. Global Vaccines Revenue Market Share by Company in 2019
Figure 37. Global Vaccines Sale Price by Company in 2019
Figure 38. Global Vaccines Consumption Market Share by Regions 2015-2020
Figure 39. Global Vaccines Value Market Share by Regions 2015-2020
Figure 40. Americas Vaccines Consumption 2015-2020 (K Pcs)
Figure 41. Americas Vaccines Value 2015-2020 ($ Millions)
Figure 42. APAC Vaccines Consumption 2015-2020 (K Pcs)
Figure 43. APAC Vaccines Value 2015-2020 ($ Millions)
Figure 44. Europe Vaccines Consumption 2015-2020 (K Pcs)
Figure 45. Europe Vaccines Value 2015-2020 ($ Millions)
Figure 46. Middle East & Africa Vaccines Consumption 2015-2020 (K Pcs)
Figure 47. Middle East & Africa Vaccines Value 2015-2020 ($ Millions)
Figure 48. Americas Vaccines Consumption Market Share by Countries in 2019
Figure 49. Americas Vaccines Value Market Share by Countries in 2019
Figure 50. Americas Vaccines Consumption Market Share by Type in 2019
Figure 51. Americas Vaccines Consumption Market Share by Application in 2019
Figure 52. United States Vaccines Consumption Growth 2015-2020 (K Pcs)
Figure 53. United States Vaccines Value Growth 2015-2020 ($ Millions)
Figure 54. Canada Vaccines Consumption Growth 2015-2020 (K Pcs)
Figure 55. Canada Vaccines Value Growth 2015-2020 ($ Millions)
Figure 56. Mexico Vaccines Consumption Growth 2015-2020 (K Pcs)
Figure 57. Mexico Vaccines Value Growth 2015-2020 ($ Millions)
Figure 58. APAC Vaccines Consumption Market Share by Countries in 2019
Figure 59. APAC Vaccines Value Market Share by Regions in 2019
Figure 60. APAC Vaccines Consumption Market Share by Type in 2019
Figure 61. APAC Vaccines Consumption Market Share by Application in 2019
Figure 62. China Vaccines Consumption Growth 2015-2020 (K Pcs)
Figure 63. China Vaccines Value Growth 2015-2020 ($ Millions)
Figure 64. Japan Vaccines Consumption Growth 2015-2020 (K Pcs)
Figure 65. Japan Vaccines Value Growth 2015-2020 ($ Millions)
Figure 66. Korea Vaccines Consumption Growth 2015-2020 (K Pcs)
Figure 67. Korea Vaccines Value Growth 2015-2020 ($ Millions)
Figure 68. Southeast Asia Vaccines Consumption Growth 2015-2020 (K Pcs)
Figure 69. Southeast Asia Vaccines Value Growth 2015-2020 ($ Millions)
Figure 70. India Vaccines Consumption Growth 2015-2020 (K Pcs)
Figure 71. India Vaccines Value Growth 2015-2020 ($ Millions)
Figure 72. Australia Vaccines Consumption Growth 2015-2020 (K Pcs)
Figure 73. Australia Vaccines Value Growth 2015-2020 ($ Millions)
Figure 74. Europe Vaccines Consumption Market Share by Countries in 2019
Figure 75. Europe Vaccines Value Market Share by Countries in 2019
Figure 76. Europe Vaccines Consumption Market Share by Type in 2019
Figure 77. Europe Vaccines Consumption Market Share by Application in 2019
Figure 78. Germany Vaccines Consumption Growth 2015-2020 (K Pcs)
Figure 79. Germany Vaccines Value Growth 2015-2020 ($ Millions)
Figure 80. France Vaccines Consumption Growth 2015-2020 (K Pcs)
Figure 81. France Vaccines Value Growth 2015-2020 ($ Millions)
Figure 82. UK Vaccines Consumption Growth 2015-2020 (K Pcs)
Figure 83. UK Vaccines Value Growth 2015-2020 ($ Millions)
Figure 84. Italy Vaccines Consumption Growth 2015-2020 (K Pcs)
Figure 85. Italy Vaccines Value Growth 2015-2020 ($ Millions)
Figure 86. Russia Vaccines Consumption Growth 2015-2020 (K Pcs)
Figure 87. Russia Vaccines Value Growth 2015-2020 ($ Millions)
Figure 88. Middle East & Africa Vaccines Consumption Market Share by Countries in 2019
Figure 89. Middle East & Africa Vaccines Value Market Share by Countries in 2019
Figure 90. Middle East & Africa Vaccines Consumption Market Share by Type in 2019
Figure 91. Middle East & Africa Vaccines Consumption Market Share by Application in 2019
Figure 92. Egypt Vaccines Consumption Growth 2015-2020 (K Pcs)
Figure 93. Egypt Vaccines Value Growth 2015-2020 ($ Millions)
Figure 94. South Africa Vaccines Consumption Growth 2015-2020 (K Pcs)
Figure 95. South Africa Vaccines Value Growth 2015-2020 ($ Millions)
Figure 96. Israel Vaccines Consumption Growth 2015-2020 (K Pcs)
Figure 97. Israel Vaccines Value Growth 2015-2020 ($ Millions)
Figure 98. Turkey Vaccines Consumption Growth 2015-2020 (K Pcs)
Figure 99. Turkey Vaccines Value Growth 2015-2020 ($ Millions)
Figure 100. GCC Countries Vaccines Consumption Growth 2015-2020 (K Pcs)
Figure 101. GCC Countries Vaccines Value Growth 2015-2020 ($ Millions)
Figure 102. Global Vaccines Consumption Growth Rate Forecast (2021-2025) (K Pcs)
Figure 103. Global Vaccines Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 104. Americas Vaccines Consumption 2021-2025 (K Pcs)
Figure 105. Americas Vaccines Value 2021-2025 ($ Millions)
Figure 106. APAC Vaccines Consumption 2021-2025 (K Pcs)
Figure 107. APAC Vaccines Value 2021-2025 ($ Millions)
Figure 108. Europe Vaccines Consumption 2021-2025 (K Pcs)
Figure 109. Europe Vaccines Value 2021-2025 ($ Millions)
Figure 110. Middle East & Africa Vaccines Consumption 2021-2025 (K Pcs)
Figure 111. Middle East & Africa Vaccines Value 2021-2025 ($ Millions)
Figure 112. United States Vaccines Consumption 2021-2025 (K Pcs)
Figure 113. United States Vaccines Value 2021-2025 ($ Millions)
Figure 114. Canada Vaccines Consumption 2021-2025 (K Pcs)
Figure 115. Canada Vaccines Value 2021-2025 ($ Millions)
Figure 116. Mexico Vaccines Consumption 2021-2025 (K Pcs)
Figure 117. Mexico Vaccines Value 2021-2025 ($ Millions)
Figure 118. Brazil Vaccines Consumption 2021-2025 (K Pcs)
Figure 119. Brazil Vaccines Value 2021-2025 ($ Millions)
Figure 120. China Vaccines Consumption 2021-2025 (K Pcs)
Figure 121. China Vaccines Value 2021-2025 ($ Millions)
Figure 122. Japan Vaccines Consumption 2021-2025 (K Pcs)
Figure 123. Japan Vaccines Value 2021-2025 ($ Millions)
Figure 124. Korea Vaccines Consumption 2021-2025 (K Pcs)
Figure 125. Korea Vaccines Value 2021-2025 ($ Millions)
Figure 126. Southeast Asia Vaccines Consumption 2021-2025 (K Pcs)
Figure 127. Southeast Asia Vaccines Value 2021-2025 ($ Millions)
Figure 128. India Vaccines Consumption 2021-2025 (K Pcs)
Figure 129. India Vaccines Value 2021-2025 ($ Millions)
Figure 130. Australia Vaccines Consumption 2021-2025 (K Pcs)
Figure 131. Australia Vaccines Value 2021-2025 ($ Millions)
Figure 132. Germany Vaccines Consumption 2021-2025 (K Pcs)
Figure 133. Germany Vaccines Value 2021-2025 ($ Millions)
Figure 134. France Vaccines Consumption 2021-2025 (K Pcs)
Figure 135. France Vaccines Value 2021-2025 ($ Millions)
Figure 136. UK Vaccines Consumption 2021-2025 (K Pcs)
Figure 137. UK Vaccines Value 2021-2025 ($ Millions)
Figure 138. Italy Vaccines Consumption 2021-2025 (K Pcs)
Figure 139. Italy Vaccines Value 2021-2025 ($ Millions)
Figure 140. Russia Vaccines Consumption 2021-2025 (K Pcs)
Figure 141. Russia Vaccines Value 2021-2025 ($ Millions)
Figure 142. Spain Vaccines Consumption 2021-2025 (K Pcs)
Figure 143. Spain Vaccines Value 2021-2025 ($ Millions)
Figure 144. Egypt Vaccines Consumption 2021-2025 (K Pcs)
Figure 145. Egypt Vaccines Value 2021-2025 ($ Millions)
Figure 146. South Africa Vaccines Consumption 2021-2025 (K Pcs)
Figure 147. South Africa Vaccines Value 2021-2025 ($ Millions)
Figure 148. Israel Vaccines Consumption 2021-2025 (K Pcs)
Figure 149. Israel Vaccines Value 2021-2025 ($ Millions)
Figure 150. Turkey Vaccines Consumption 2021-2025 (K Pcs)
Figure 151. Turkey Vaccines Value 2021-2025 ($ Millions)
Figure 152. GCC Countries Vaccines Consumption 2021-2025 (K Pcs)
Figure 153. GCC Countries Vaccines Value 2021-2025 ($ Millions)
Figure 154. GSK Vaccines Market Share (2018-2020)
Figure 155. Tiantan Vaccines Market Share (2018-2020)
Figure 156. Sanofi Vaccines Market Share (2018-2020)
Figure 157. Pfizer Vaccines Market Share (2018-2020)
Figure 158. Novartis(GSK) Vaccines Market Share (2018-2020)
Figure 159. Merck Vaccines Market Share (2018-2020)
Figure 160. J&J(Crucell) Vaccines Market Share (2018-2020)
Figure 161. CSL Vaccines Market Share (2018-2020)
Figure 162. China National Biotec Vaccines Market Share (2018-2020)
Figure 163. MedImmune LLC Vaccines Market Share (2018-2020)
Figure 164. Hualan Vaccines Market Share (2018-2020)
Figure 165. Jintan Vaccines Market Share (2018-2020)
Figure 166. Hissen Vaccines Market Share (2018-2020)
Figure 167. Kangtai Vaccines Market Share (2018-2020)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs